138 related articles for article (PubMed ID: 22436610)
1. The oncoprotein ErbB3 is endocytosed in the absence of added ligand in a clathrin-dependent manner.
Sak MM; Breen K; Rønning SB; Pedersen NM; Bertelsen V; Stang E; Madshus IH
Carcinogenesis; 2012 May; 33(5):1031-9. PubMed ID: 22436610
[TBL] [Abstract][Full Text] [Related]
2. Pertuzumab counteracts the inhibitory effect of ErbB2 on degradation of ErbB3.
Sak MM; Szymanska M; Bertelsen V; Hasmann M; Madshus IH; Stang E
Carcinogenesis; 2013 Sep; 34(9):2031-8. PubMed ID: 23698633
[TBL] [Abstract][Full Text] [Related]
3. ErbB3 expression and dimerization with EGFR influence pancreatic cancer cell sensitivity to erlotinib.
Frolov A; Schuller K; Tzeng CW; Cannon EE; Ku BC; Howard JH; Vickers SM; Heslin MJ; Buchsbaum DJ; Arnoletti JP
Cancer Biol Ther; 2007 Apr; 6(4):548-54. PubMed ID: 17457047
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the EGFR/ErbB signalling by clathrin in response to various ligands in hepatocellular carcinoma cell lines.
Liu Y; Calmel C; Desbois-Mouthon C; Sobczak-Thépot J; Karaiskou A; Praz F
J Cell Mol Med; 2020 Jul; 24(14):8091-8102. PubMed ID: 32515546
[TBL] [Abstract][Full Text] [Related]
5. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
[TBL] [Abstract][Full Text] [Related]
6. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
Feroz K; Williams E; Riese DJ
Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R
Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850
[TBL] [Abstract][Full Text] [Related]
8. Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation.
Contessa JN; Abell A; Mikkelsen RB; Valerie K; Schmidt-Ullrich RK
Breast Cancer Res Treat; 2006 Jan; 95(1):17-27. PubMed ID: 16267617
[TBL] [Abstract][Full Text] [Related]
9. Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.
Li Z; Mei Y; Liu X; Zhou M
Cell Signal; 2007 Mar; 19(3):466-71. PubMed ID: 16978839
[TBL] [Abstract][Full Text] [Related]
10. Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers.
Muthuswamy SK; Gilman M; Brugge JS
Mol Cell Biol; 1999 Oct; 19(10):6845-57. PubMed ID: 10490623
[TBL] [Abstract][Full Text] [Related]
11. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F
Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor-stimulated Akt phosphorylation requires clathrin or ErbB2 but not receptor endocytosis.
Garay C; Judge G; Lucarelli S; Bautista S; Pandey R; Singh T; Antonescu CN
Mol Biol Cell; 2015 Oct; 26(19):3504-19. PubMed ID: 26246598
[TBL] [Abstract][Full Text] [Related]
13. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
Pedersen NM; Breen K; Rødland MS; Haslekås C; Stang E; Madshus IH
Mol Cancer Res; 2009 Feb; 7(2):275-84. PubMed ID: 19208749
[TBL] [Abstract][Full Text] [Related]
14. ErbB3 Ligand Heregulin1 Is a Major Mitogenic Factor for Uncontrolled Lung Cancer Cell Proliferation.
Ma S; Jia S; Ren Y; Cao B; Zha X; He J; Chen C
Neoplasia; 2019 Apr; 21(4):343-352. PubMed ID: 30831376
[TBL] [Abstract][Full Text] [Related]
15. Functional isolation of activated and unilaterally phosphorylated heterodimers of ERBB2 and ERBB3 as scaffolds in ligand-dependent signaling.
Zhang Q; Park E; Kani K; Landgraf R
Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13237-42. PubMed ID: 22733765
[TBL] [Abstract][Full Text] [Related]
16. Betacellulin (BTC) Biases the EGFR To Dimerize with ErbB3.
Rush JS; Peterson JL; Ceresa BP
Mol Pharmacol; 2018 Dec; 94(6):1382-1390. PubMed ID: 30249613
[TBL] [Abstract][Full Text] [Related]
17. Interaction with epsin 1 regulates the constitutive clathrin-dependent internalization of ErbB3.
Szymanska M; Fosdahl AM; Raiborg C; Dietrich M; Liestøl K; Stang E; Bertelsen V
Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1179-88. PubMed ID: 26975582
[TBL] [Abstract][Full Text] [Related]
18. Heterodimerization of the epidermal-growth-factor (EGF) receptor and ErbB2 and the affinity of EGF binding are regulated by different mechanisms.
Johannessen LE; Haugen KE; østvold AC; Stang E; Madshus IH
Biochem J; 2001 May; 356(Pt 1):87-96. PubMed ID: 11336639
[TBL] [Abstract][Full Text] [Related]
19. Expression of heregulin alpha, erbB2, and erbB3 and their influences on proliferation of gastric epithelial cells.
Noguchi H; Sakamoto C; Wada K; Akamatsu T; Uchida T; Tatsuguchi A; Matsui H; Fukui H; Fujimori T; Kasuga M
Gastroenterology; 1999 Nov; 117(5):1119-27. PubMed ID: 10535875
[TBL] [Abstract][Full Text] [Related]
20. Dimerization drives EGFR endocytosis through two sets of compatible endocytic codes.
Wang Q; Chen X; Wang Z
J Cell Sci; 2015 Mar; 128(5):935-50. PubMed ID: 25588832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
